Regulation of Effector and Memory T-cell Functions by Type I Interferon

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2011 Feb 16

PMID 21320124

Citations 143

Authors

Jonathan P Huber

J David Farrar

Affiliations

Soon will be listed here.

Abstract

Type I interferon (IFN-α/β) is comprised of a family of highly related molecules that exert potent antiviral activity by interfering with virus replication and spread. IFN-α/β secretion is tightly regulated through pathogen sensing pathways that are operative in most somatic cells. However, specialized antigen-presenting plasmacytoid dendritic cells are uniquely equipped with the capacity to secrete extremely high levels of IFN-α/β, suggesting a key role for this cytokine in priming adaptive T-cell responses. Recent studies in both mice and humans have demonstrated a role for IFN-α/β in directly influencing the fate of both CD4(+) and CD8(+) T cells during the initial phases of antigen recognition. As such, IFN-α/β, among other innate cytokines, is considered an important 'third signal' that shapes the effector and memory T-cell pool. Moreover, IFN-α/β also serves as a counter-regulator of T helper type 2 and type 17 responses, which may be important in the treatment of atopy and autoimmunity, and in the development of novel vaccine adjuvants.

Citing Articles

Immunization induces inflammation in the mouse heart during spaceflight.

Veliz A, Hughes L, Carrillo D, Pecaut M, Kearns-Jonker M BMC Genomics. 2025; 26(1):229.

PMID: 40065216 PMC: 11892206. DOI: 10.1186/s12864-025-11426-y.

The Tumour Microenvironment and Epigenetic Regulation in Pathogenic Variant-Associated Breast Cancers.

Tay J, Ho J, Cheo F, Iqbal J Cancers (Basel). 2024; 16(23).

PMID: 39682099 PMC: 11639800. DOI: 10.3390/cancers16233910.

Engineered T cells for Colorectal Cancer.

Rus Bakarurraini N, Kamarudin A, Jamal R, Abu N Immunotherapy. 2024; 16(14-15):987-998.

PMID: 39229803 PMC: 11485792. DOI: 10.1080/1750743X.2024.2391733.

Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment.

Sumi T, Harada K Front Immunol. 2024; 15:1329162.

PMID: 39185419 PMC: 11341427. DOI: 10.3389/fimmu.2024.1329162.

Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.

Fang C, Cheng Y, Lin S, Lai W, Liao L, Chiu Y BMC Cancer. 2024; 24(1):980.

PMID: 39118069 PMC: 11312821. DOI: 10.1186/s12885-024-12707-7.

References

Martin D, Murali-Krishna K, Tarleton R . Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling. Infect Immun. 2010; 78(7):3154-9. PMC: 2897408. DOI: 10.1128/IAI.00275-10. View

Moschen A, Geiger S, Krehan I, Kaser A, Tilg H . Interferon-alpha controls IL-17 expression in vitro and in vivo. Immunobiology. 2008; 213(9-10):779-87. DOI: 10.1016/j.imbio.2008.07.022. View

Yan H, Krishnan K, Greenlund A, Gupta S, Lim J, Schreiber R . Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J. 1996; 15(5):1064-74. PMC: 450004. View

Hardy M, Owczarek C, Jermiin L, Ejdeback M, Hertzog P . Characterization of the type I interferon locus and identification of novel genes. Genomics. 2004; 84(2):331-45. DOI: 10.1016/j.ygeno.2004.03.003. View

DOLY J, Civas A, Navarro S, Uze G . Type I interferons: expression and signalization. Cell Mol Life Sci. 1998; 54(10):1109-21. PMC: 11147243. DOI: 10.1007/s000180050240. View

Stark G, Kerr I, Williams B, Silverman R, Schreiber R . How cells respond to interferons. Annu Rev Biochem. 1998; 67:227-64. DOI: 10.1146/annurev.biochem.67.1.227. View

Farrar J, Smith J, MURPHY T, Leung S, Stark G, Murphy K . Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat Immunol. 2001; 1(1):65-9. DOI: 10.1038/76932. View

Davis A, Ramos H, Davis L, Farrar J . Cutting edge: a T-bet-independent role for IFN-alpha/beta in regulating IL-2 secretion in human CD4+ central memory T cells. J Immunol. 2008; 181(12):8204-8. PMC: 2596627. DOI: 10.4049/jimmunol.181.12.8204. View

Persky M, Murphy K, Farrar J . IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene. J Immunol. 2004; 174(1):294-301. DOI: 10.4049/jimmunol.174.1.294. View

10.

Ouyang W, Ranganath S, Weindel K, Bhattacharya D, MURPHY T, Sha W . Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998; 9(5):745-55. DOI: 10.1016/s1074-7613(00)80671-8. View

11.

Mattei F, Schiavoni G, Belardelli F, Tough D . IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol. 2001; 167(3):1179-87. DOI: 10.4049/jimmunol.167.3.1179. View

12.

Hegazy A, Peine M, Helmstetter C, Panse I, Frohlich A, Bergthaler A . Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity. 2010; 32(1):116-28. DOI: 10.1016/j.immuni.2009.12.004. View

13.

Pene J, Rousset F, Briere F, Chretien I, Bonnefoy J, Spits H . IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A. 1988; 85(18):6880-4. PMC: 282082. DOI: 10.1073/pnas.85.18.6880. View

14.

Havenar-Daughton C, Kolumam G, Murali-Krishna K . Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol. 2006; 176(6):3315-9. DOI: 10.4049/jimmunol.176.6.3315. View

15.

Rogge L, DAmbrosio D, Biffi M, Penna G, Minetti L, Presky D . The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol. 1998; 161(12):6567-74. View

16.

Strengell M, Julkunen I, Matikainen S . IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells. J Leukoc Biol. 2004; 76(2):416-22. DOI: 10.1189/jlb.1003488. View

17.

Placek K, Gasparian S, Coffre M, Maiella S, Sechet E, Bianchi E . Integration of distinct intracellular signaling pathways at distal regulatory elements directs T-bet expression in human CD4+ T cells. J Immunol. 2009; 183(12):7743-51. DOI: 10.4049/jimmunol.0803812. View

18.

Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko S, Renauld J . Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem. 2004; 279(31):32269-74. DOI: 10.1074/jbc.M404789200. View

19.

Cui W, Joshi N, Jiang A, Kaech S . Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation. Vaccine. 2009; 27(15):2177-87. PMC: 2803112. DOI: 10.1016/j.vaccine.2009.01.088. View

20.

Paul W, Zhu J . How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol. 2010; 10(4):225-35. PMC: 3496776. DOI: 10.1038/nri2735. View